Kalii Chloridum/Natrii Chloridum B. Braun (Potassium Chloride, Sodium Chloride)

The injection delivers potassium and sodium ions directly into the bloodstream, raising extracellular concentrations of these electrolytes. Potassium helps maintain cellular membrane potential and cardiac rhythm, while sodium contributes to osmotic balance and fluid distribution. Together they re‑establish electrolyte homeostasis and support normal physiological functions.

The dose of Kalii Chloridum/Natrii Chloridum B. Braun is determined by the prescribing clinician based on the patient’s electrolyte levels, clinical condition, and renal function. The healthcare professional will calculate the appropriate volume and concentration required for safe and effective therapy.

Safety data for Kalii Chloridum/Natrii Chloridum B. Braun in pregnancy and lactation are limited. Use only if clearly needed and after a risk‑benefit assessment by the treating physician. The prescriber should consider maternal and fetal electrolyte requirements before administration.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details (including cold‑chain if required) and import documentation.

Kalii Chloridum/Natrii Chloridum B. Braun provides a combined potassium and sodium formulation in a single IV solution, which can simplify dosing compared with separate potassium or sodium preparations. It offers rapid correction of both electrolytes simultaneously, whereas other products may target only one ion or require multiple infusions.

The injection should be stored at 2‑8 °C, kept refrigerated, protected from light, and must not be frozen or shaken. Before use, inspect the vial for particulate matter or discoloration and allow it to reach room temperature if required by the administration protocol.

Kalii Chloridum/Natrii Chloridum B. Braun is administered intravenously. The solution is typically diluted in an appropriate compatible IV fluid and infused over a controlled period, as directed by the prescribing clinician, to avoid rapid shifts in electrolyte concentrations.

Serious risks include hyperkalemia, which can cause life‑threatening cardiac arrhythmias, and hypernatremia, which may lead to neurological complications. Anaphylactic reactions, severe vein irritation, and renal impairment exacerbation are also possible and require immediate medical attention.

Patients with known hypersensitivity to potassium chloride, sodium chloride, or any component of the formulation should not receive this injection. It is also contraindicated in individuals with severe renal failure, uncontrolled hyperkalemia, or uncontrolled hypernatremia unless closely monitored by a specialist.